You are here

Programme at a Glance - virtual EASD Annual Meeting 2021

All times shown are CEST - Central European Summer Time

Tuesday, 28 September 2021

 

Moscow
Hall

Paris
Hall

London
Hall

Madrid
Hall

Barcelona
Hall

St Petersburg
Hall

Rome
Hall

Athens Hall

10:00
10:30

Opening Ceremony and Presidential Address

       

10:30
11:15

53rd Claude Bernard Lecture

       

11:30
13:00

OP 1

OP 2

OP 3

OP 4

OP 5

OP 6

Short Oral Discussion
Event A

 

13:15
14:45

OP 7

OP 8

OP 9

OP 10

OP 11

OP 12

Short Oral Discussion
Event B

EFSD Mentorship Programme
(13:00 - 14:00)

15:00
16:00

36th Camillo Golgi Lecture

15th Albert Renold Lecture

Rising Star Symposium

     

16:00
16:40

       

16:40
17:20

Daily roundup / wrap up

Wednesday, 29 September 2021

 

Moscow
Hall

Paris
Hall

London
Hall

Madrid
Hall

Barcelona
Hall

St Petersburg
Hall

Rome
Hall

Athens Hall

Milan Hall

10:00
11:30

EASD/ADA Symposium: Optimising diabetes diagnosis, prevention and care: Is precision medicine the answer?

Diabetologia Symposium: Learning from machines – AI in diabetes research and care

EASD/JDRF Symposium: Beta cell (dys)function in type 1 diabetes

Hypoglycaemia: unanswered questions

The liver, heart and kidney triangle: linking major organs in the complications of dysglycaemia

Fifty shades of ectopic fat in diabetes

EASD/AASD Joint Symposium: Medical nutrition therapy, physical activity and exercise for diabetes

 

EASD e-Learning: Insulin@100: insulin in specific populations

11:45
13:15

OP 13

OP 14

OP 15

OP 16

OP 17

OP 18

Short Oral Discussion
Event C

 

EASD e-Learning: Fear of hypoglycaemia
(12:00 - 13:30)

13:30
15:00

OP 19

OP 20

OP 21

OP 22

OP 23

OP 24

Short Oral Discussion
Event D

EUDF Symposium: It takes more than just a registry to improve care
(14:00 - 16:00)

EASD e-Learning: Non-alcoholic fatty liver disease
(14:00 - 15:30)

15:15
16:15

EASD/Novo Nordisk Foundation Diabetes Prize for Excellence

     

New data from Dapa-CKD

EASD e-Learning: Insulin@100: insulin and exercise
(16:15 - 17:30)

16:30
17:30

 

SARS-CoV-2 in human islets: a diabetes epidemic in the making?

Adipose tissue as a therapeutic target in type 2 diabetes: What should we aim for?

More from closed loops

100 years insulin treatment

It is time to be active

Results from TriMASTER: a 3-way cross-over trial of precision medicine strategy of 2nd/3rd line therapy in type 2 diabetes

 

17:30
18:10

Daily roundup / wrap up

 

Thursday, 30 September 2021

 

Moscow
Hall

Paris
Hall

London
Hall

Madrid
Hall

Barcelona
Hall

St Petersburg
Hall

Rome
Hall

Athens Hall

Milan Hall

10:00
11:30

Prediabetes: Does it really matter?

EASD/ESC Symposium: How come not every patient with diabetes develops vascular complications?

Perspectives of the diabetic foot syndrome

New ways to understand kidney disease in diabetes

Inter-organ communication in diabetes and systemic energy homeostasis

5 years of cardiovascular benefits of GLP-1 receptor agonists: evidence from recent cardiovascular outcomes trials

EASD/ESE Symposium: Diabetes and bone

Next step in incretin therapy: from single to dual agonism

EASD e-Learning: Obesity and type 2 diabetes

11:45
13:15

OP 25

OP 26

OP 27

OP 28

OP 29

OP 30

Short Oral Discussion
Event E

 

EASD e-Learning: Insulin@100: in combination with GLP-1 RAs and fixed ratio combinations
(12:00 - 13:30)

13:30
15:00

OP 31

OP 32

OP 33

OP 34

OP 35

OP 36

Short Oral Discussion
Event F

EASD e-Learning: Diabetic neuropathy
(14:00 - 15:30)

15:15
16:00

Induction of Honorary Members

56th Minkowski Lecture

       

EASD e-Learning: Insulin@100: insulin in hospital settings
(16:00 - 17:30)

16:15
17:15

Michael Berger Debate: Who suffers more: Are women with diabetes at higher cardiovascular risk?

The future of incretin-based treatments

Will human-first approaches finally get to the root cause of diabetic vascular disease?

Devices support diabetes treatment

Small vessels, big problems: cerebral small-vessel disease - a potential microvascular complication of diabetes

Harnessing intracellular pathways for therapy

INNODIA - Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes

EMPEROR Preserved Study

17:15
17:55

Daily roundup / wrap up

 

Friday, 1 October 2021

 

Moscow
Hall

Paris
Hall

London
Hall

Madrid
Hall

Barcelona
Hall

St Petersburg
Hall

Rome
Hall

Milan Hall

10:00
11:00

Retinopathy and artificial intelligence

Current guidelines on diabetes management

Importance of insulin clearance in the regulation of glucose metabolism

Debate: Preventing diabetic complications – 100 years on from insulin: Which of the newer classes will prevail?

In-hospital management of hyperglycaemia: still a Cinderella of diabetes management?

COVID-19 infection in people with diabetes: a risky combination

EASD-Lancet Symposium: Treatment of obesity: the future of diabetes treatment?

EASD e-Learning: Insulin@100: physiological replacement
(10:00 - 11:30)

11:15
12:15

OP 37

OP 38

OP 39

OP 40

OP 41

OP 42

Finerenone: a new approach to kidney protection in patients with type 2 diabetes
(11:15 - 12:45)

 

12:30
13:30

OP 43

OP 44

OP 45

OP 46

OP 47

 

EASD e-Learning: Insulin@100: novel technologies
(12:00 - 13:30)

13:45
15:15

Management of type 1 diabetes: ADA-EASD Consensus Report 2021

Going to bed with diabetes

What do the cells talk about and how? Extracellular vesicles: biomarker, diagnostic tool or therapeutic vehicle

My cells are getting old! Ageing in diabetes

Turning stem cells into beta cells

Major results from the Glycaemia Reduction Approaches in Diabetes: a Comparative Effectiveness (GRADE) Study

A novel approach to problematic hypoglycaemia: the HARPdoc RCT

EASD e-Learning: Real World Evidence
(14:00 - 15:30)
 

15:15
15:55

Daily roundup / wrap up

16:15
17:30

     

EASD General Assembly
(for EASD members only)

Invitation Letter
(incl. agenda and minutes)

  

Please note that the programme may be subject to change.

Non-commercial satellite symposia on the occasion of the 57th EASD Annual Meeting

Monday,
27 Sept 2021

IDF Europe Symposium: The use of data in diabetes - a patient-centred approach
14:30 - 15:45, Berlin Hall

Tuesday,
28 Sept 2021

DFSG Symposium: What do I need to know about the diabetic foot today?
08:30 - 10:00, Berlin Hall

DIAB IMAGE - Biomedical Imaging in Diabetes Study Group Symposium
10:30 - 12:30, Berlin Hall

D&CVD Symposium: Towards heart failure and cardiometabolic management in type 2 diabetes
13:00 - 15:00, Berlin Hall

RMSG Symposium: Reactive metabolites and increased risk of severe COVID-19 disease in obesity and diabetes
16:00 - 17:00, Berlin Hall

Wednesday,
29 Sept 2021

EDNSG Symposium: Hot topic in diabetes kidney disease
08:00 - 10:30, Berlin Hall

MSSG Symposium: Creating a network on metabolic surgery for the treatment of metabolic disease
11:00 - 12:00, Berlin Hall

DESG Symposium: Therapeutic patients' education - One year experience during COVID-19 pandemics
12:30 - 14:30, Berlin Hall

EGIR Symposium: What's the matter with adipose tissue and insulin resistance?
15:00 - 15:45, Berlin Hall

NAFLD Symposium: What's the matter with adipose tissue and hepatic steatosis?
16:15 - 17:00, Berlin Hall

Thursday,
30 Sept 2021

PCDE Symposium: Research output during the COVID 19 pandemic
08:00 - 09:30, Berlin Hall

NEURODIAB Symposium: Diabetic neuropathy - the unattended borderline
10:00 - 12:00, Berlin Hall

HSRHE Symposium: Health care, health outcomes and costs for people with diabetes during the COVID-19 pandemic and beyond
12:30 - 14:30, Berlin Hall

IHSG Symposium: Long-term cognitive consequences of severe hypoglycaemia
15:00 - 17:00, Berlin Hall

 

Industry Sessions

View the Industry Sessions Programme here: https://www.easd-industry.com/